An interventional study of Depression e-Learning A and Depression e-Learning B in Depression and Anxiety, sponsored by McMaster University. Completed at 1 site in Canada. Open to participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-30.
Sponsored by McMaster University · Not applicable, Interventional, and Other
In this proposal, the investigators plan to study the impact of In this proposal, we plan to study the impact of e-learning on mental health literacy and stigma related to anxiety and depression. Participants will be randomized to one of four groups - Depression e-Learning A, Depression e-Learning B, Anxiety e-Learning A, and Anxiety e-Learning B. All participants will be given access to all e-learning at the conclusion of the study.
8,057 studies on the registry are indexed under Depression; 1,643 are open to participants now.
This study's enrollment of 125 is above the median of 84 across 6,718 interventional studies indexed under Depression.
Browse Depression studies →McMaster University is the lead sponsor of 720 studies on the registry; 124 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Depression e-Learning A
Other: Anxiety e-Learning A
Other: Depression e-Learning B
Other: Anxiety e-Learning B
Participants in Depression e-Learning A will be provided e-learning about depression, consisting of following components: 1. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson. 1\. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
Participants in Depression e-Learning B will be provided e-learning about depression, consisting of following components: 1. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson. 1\. One multimedia e-learning lesson on depression; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
Participants in Anxiety e-Learning A will be provided e-learning about anxiety, consisting of following components: 1. One multimedia e-learning lesson on anxiety; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
Participants in Anxiety e-Learning B will be provided e-learning about anxiety, consisting of following components: 1. One multimedia e-learning lesson on anxiety; 2. A series of 4 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lesson.
Change from baseline in the Depression Literacy Questionnaire
The Depression Literacy Questionnaire assesses mental health literacy specific to depression. The questionnaire consists of 22 items which are true or false. Respondents can answer each item with one of three options - true, false, or I don't know. Each correct response receives one point. Higher scores indicate higher depression literacy.
Time frame: 0, 2, 4 weeks
Change from baseline in the Anxiety Literacy Questionnaire
The Anxiety Literacy Questionnaire assesses mental health literacy specific to anxiety. The questionnaire consists of 22 items which are true or false. Respondents can answer each item with one of three options - true, false, or I don't know. Each correct response receives one point. Higher scores indicate higher depression literacy.
Time frame: 0, 2, 4 weeks
Change from baseline in the Depression Stigma Scale
The Depression Stigma Scale is a 9-item assessment designed to measure stigma associated with depression with two subscales: personal and perceived. The Personal Stigma Subscale measures stigma in the respondents' own attitudes towards depression by asking them to indicate how strongly they personally agree with nine statements about depression. The Perceived Stigma Subscale measures the respondent's perception about the attitudes of others towards depression by asking them to indicate what they think most other people believe about the same nine statements. Responses to each item are measured on a five-point scale (ranging from zero 'strongly disagree' to four 'strongly agree'). Higher scores indicate higher levels of depression stigma.
Time frame: 0, 2, 4 weeks
Change from baseline in the Generalized Anxiety Stigma Scale
The Generalised Anxiety Stigma Scale is analogous, but designed to measure stigma associated with anxiety disorders. It has two subscales: personal and perceived. The Personal Stigma Subscale measures stigma in the respondents' own attitudes towards anxiety disorders by asking them to indicate how strongly they personally agree with 10 statements about anxiety disorders. The Perceived Stigma Subscale measures the respondent's perception about the attitudes of others towards anxiety disorders by asking them to indicate what they think most other people believe about the same 10 statements. Responses to each item are measured on a five-point scale (ranging from zero 'strongly disagree' to four 'strongly agree'). Higher scores indicate higher levels of anxiety stigma.
Time frame: 0, 2, 4 weeks
Participant satisfaction
A custom satisfaction questionnaire data adapted from the Information Assessment Method For All (IAM4all) will be collected and saved to assess satisfaction with the intervention.
Time frame: 2 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
McMaster University